tirzepatide approved FDA approval for Zepbound: FSU researcher available for context on newly weight loss treatment FDA approves weight-loss drug Zepbound

One company has already announced that it will stop manufacturing the doses of semaglutide that are available as Wegovy, but will continue to manufacture personalized doses

These cardiovascular benefits appear independent of weight loss alone, suggesting direct metabolic effects on lipid handling

Saxelin M (2008) Probiotic formulations and applications, the current probiotics market, and changes in the marketplace: a European perspective

Paracetamol (acetaminophen) can deplete glutathione, leading to potentially fatal hepatotoxicity, especially in individuals with low baseline intrahepatic glutathione status, including those with HIV, chronic hepatitis C, cystic fibrosis, malnutrition, and anorexia nervosa (Kalsi 2011)